Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Adaptive Biotechnologies Corp (ADPT)  
$11.65 0.14 (1.19%) as of 4:30 Mon 6/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 160,489,000
Market Cap: 1.87(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $3.37 - $12.16
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Adaptive Biotechnologies is a commercial-stage company developing the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Co.'s immune medicine platform applies its main technologies to read the genetic code of a patient's immune system. Co.'s clinical diagnostic product, clonoSEQ, is authorized by the Food and Drug Administration for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia and chronic lymphocytic leukemia and is also available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 72,270 1,420,393 1,447,563 1,645,412
Total Sell Value $537,126 $11,194,180 $11,316,494 $12,049,351
Total People Sold 2 10 11 13
Total Sell Transactions 3 20 22 33
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 913
  Page 1 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Piskel Kyle Chief Financial Officer   •       –      –    2025-05-16 4/A S $8.89 $17,149 D/D (1,929) 269,581     -
   Piskel Kyle Chief Financial Officer   •       –      –    2025-05-16 4 S $8.89 $17,149 D/D (1,929) 277,396 -30%     
   Piskel Kyle Chief Financial Officer   •       –      –    2025-05-15 4 A $0.00 $0 D/D 7,815 279,325     -
   Robins Harlan S Chief Scientific Officer   •       –      –    2025-05-01 4 AS $7.35 $502,828 D/D (68,412) 1,279,524 60%     
   Robins Harlan S Chief Scientific Officer   •       –      –    2025-05-01 4 OE $6.32 $432,364 D/D 68,412 1,347,936     -
   Piskel Kyle Chief Financial Officer   •       –      –    2025-03-14 4 OE $6.32 $15,800 D/D 2,500 271,510     -
   Burris Michelle Director   –       •      –    2025-03-13 4 S $7.19 $260,932 D/D (36,291) 15,394 -64%     
   Hershberg Robert Director   –       •      –    2025-03-12 4 S $7.59 $402,270 D/D (53,000) 69,690 -55%     
   Neupert Peter M Director   –       •      –    2025-03-10 4 S $7.05 $70,500 D/D (10,000) 224,690 -77%     
   Neupert Peter M Director   –       •      –    2025-03-10 4 OE $4.07 $203,500 D/D 50,000 234,690     -
   Robins Chad M CEO and Chairman   •       •      –    2025-03-06 4 S $7.64 $780,946 D/D (102,218) 2,959,249 -52%     
   Burris Michelle Director   –       •      –    2025-03-06 4 AS $7.94 $124,372 D/D (15,664) 51,685 52%     
   Robins Chad M CEO and Chairman   •       •      –    2025-03-05 4 A $0.00 $0 D/D 247,117 3,061,467     -
   Robins Chad M CEO and Chairman   •       •      –    2025-03-05 4 S $6.98 $819,471 D/D (117,351) 2,814,350 -47%     
   Bobulsky Susan Chief Commercial Officer, MRD   •       –      –    2025-03-05 4 S $6.98 $181,641 D/D (26,023) 347,238 -47%     
   Rubinstein Julie President and COO   •       –      –    2025-03-05 4 S $6.98 $415,540 D/D (59,505) 588,249 -47%     
   Benzeno Sharon Chief Commercial Ofc Imm Med   •       –      –    2025-03-05 4 S $6.98 $311,792 D/D (44,665) 392,723 -47%     
   Lo Francis Chief People Officer   •       –      –    2025-03-05 4 S $6.98 $145,845 D/D (20,875) 332,846 -47%     
   Robins Harlan S Chief Scientific Officer   •       –      –    2025-03-05 4 S $6.98 $675,219 D/D (96,656) 1,279,524 -47%     
   Piskel Kyle Chief Financial Officer   •       –      –    2025-03-05 4 S $6.97 $72,072 D/D (10,320) 269,010 -47%     
   Robins Chad M CEO and Chairman   •       •      –    2025-03-04 4 A $0.00 $0 D/D 355,000 2,931,701     -
   Hershberg Robert Director   –       •      –    2025-03-04 4 A $0.00 $0 D/D 15,394 122,690     -
   Bobulsky Susan Chief Commercial Officer, MRD   •       –      –    2025-03-04 4 A $0.00 $0 D/D 119,971 373,261     -
   Rubinstein Julie President and COO   •       –      –    2025-03-04 4 A $0.00 $0 D/D 175,000 647,754     -
   Benzeno Sharon Chief Commercial Ofc Imm Med   •       –      –    2025-03-04 4 A $0.00 $0 D/D 109,973 437,388     -
  913 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us